ATIR101 + T-cell depleted HSCT from a related, haploidentical donor

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

ATIR101 + T-cell depleted HSCT from a related, haploidentical donor
Treatment and conditionWhere it standsTrials
ATIR101 + T-cell depleted HSCT from a related, haploidentical donor for graft vs host diseaseTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
ATIR101 + T-cell depleted HSCT from a related, haploidentical donor for myelodysplastic syndromesTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1